Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Federal Realty Investment Trust (FRT) Reports Q2 Earnings: What Key Metrics Have to Say
Federal Realty Investment Trust (FRT) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Federal Realty Investment Trust (FRT) reported revenue of $311.52 million, up 5.2% over the same period last year. EPS came in at $1.91, compared to $1.32 in the

Transcat, Inc. (TRNS) Tops Q1 Earnings and Revenue Estimates
Transcat, Inc. (TRNS) Tops Q1 Earnings and Revenue Estimates

Transcat, Inc. (TRNS) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.48 per share a year ago. These

TKO Group Holdings (TKO) Lags Q2 Earnings Estimates
TKO Group Holdings (TKO) Lags Q2 Earnings Estimates

TKO Group Holdings (TKO) came out with quarterly earnings of $1.17 per share, missing the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $0.72 per share a year ago. These

McKesson (MCK) Surpasses Q1 Earnings and Revenue Estimates
McKesson (MCK) Surpasses Q1 Earnings and Revenue Estimates

McKesson (MCK) came out with quarterly earnings of $8.26 per share, beating the Zacks Consensus Estimate of $8.23 per share. This compares to earnings of $7.88 per share a year ago. These figures

MediaAlpha, Inc. (MAX) Beats Q2 Earnings and Revenue Estimates
MediaAlpha, Inc. (MAX) Beats Q2 Earnings and Revenue Estimates

MediaAlpha, Inc. (MAX) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.07 per share a year ago. These

Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates
Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates

Protagonist Therapeutics (PTGX) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to a loss of $0.5 per share a year ago. These

National Health Investors (NHI) Tops Q2 FFO Estimates
National Health Investors (NHI) Tops Q2 FFO Estimates

National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to FFO of $1.18 per

MetLife (MET) Q2 Earnings and Revenues Miss Estimates
MetLife (MET) Q2 Earnings and Revenues Miss Estimates

MetLife (MET) came out with quarterly earnings of $2.02 per share, missing the Zacks Consensus Estimate of $2.19 per share. This compares to earnings of $2.28 per share a year ago. These figures are

AppLovin (APP) Tops Q2 Earnings and Revenue Estimates
AppLovin (APP) Tops Q2 Earnings and Revenue Estimates

AppLovin (APP) came out with quarterly earnings of $2.26 per share, beating the Zacks Consensus Estimate of $1.99 per share. This compares to earnings of $0.89 per share a year ago. These figures

AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates

AnaptysBio, Inc. (ANAB) came out with a quarterly loss of $1.34 per share versus the Zacks Consensus Estimate of a loss of $1.5. This compares to a loss of $1.71 per share a year ago. These figures

Amdocs (DOX) Q3 Earnings and Revenues Beat Estimates
Amdocs (DOX) Q3 Earnings and Revenues Beat Estimates

Amdocs (DOX) came out with quarterly earnings of $1.72 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.62 per share a year ago. These figures are

Staar Surgical (STAA) Reports Q2 Loss, Beats Revenue Estimates
Staar Surgical (STAA) Reports Q2 Loss, Beats Revenue Estimates

Staar Surgical (STAA) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to earnings of $0.33 per share a year ago. These figures

e.l.f. Beauty (ELF) Surpasses Q1 Earnings and Revenue Estimates
e.l.f. Beauty (ELF) Surpasses Q1 Earnings and Revenue Estimates

e.l.f. Beauty (ELF) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $1.1 per share a year ago. These

Paycom Software (PAYC) Beats Q2 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Data analytics provider, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/d1295d04-cceb-4f1c-be2b-32ca46621336.png
Paycom Software (PAYC) Beats Q2 Earnings and Revenue Estimates

Paycom Software (PAYC) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.62 per share a year ago. These

HubSpot (HUBS) Surpasses Q2 Earnings and Revenue Estimates
HubSpot (HUBS) Surpasses Q2 Earnings and Revenue Estimates

HubSpot (HUBS) came out with quarterly earnings of $2.19 per share, beating the Zacks Consensus Estimate of $2.12 per share. This compares to earnings of $1.94 per share a year ago. These figures

Corpay (CPAY) Meets Q2 Earnings Estimates
Corpay (CPAY) Meets Q2 Earnings Estimates

Corpay (CPAY) came out with quarterly earnings of $5.13 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $4.55 per share a year ago. These figures are adjusted for

Alto Ingredients (ALTO) Reports Q2 Loss, Beats Revenue Estimates
Alto Ingredients (ALTO) Reports Q2 Loss, Beats Revenue Estimates

Alto Ingredients (ALTO) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.05 per share a year ago. These figures

Do Options Traders Know Something About PDS Stock We Don't?
Do Options Traders Know Something About PDS Stock We Don't?

Investors in Precision Drilling Corporation PDS need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 19, 2025 $70 Put had some of the

Symbotic Inc. (SYM) Reports Q3 Loss, Beats Revenue Estimates
Symbotic Inc. (SYM) Reports Q3 Loss, Beats Revenue Estimates

Symbotic Inc. (SYM) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of $0.04. This compares to a loss of $0.02 per share a year ago. These figures are adjusted

Fortinet (FTNT) Beats Q2 Earnings and Revenue Estimates
Fortinet (FTNT) Beats Q2 Earnings and Revenue Estimates

Fortinet (FTNT) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.57 per share a year ago. These figures

Realty Income Corp. (O) Misses Q2 FFO Estimates
Realty Income Corp. (O) Misses Q2 FFO Estimates

Realty Income Corp. (O) came out with quarterly funds from operations (FFO) of $1.05 per share, missing the Zacks Consensus Estimate of $1.06 per share. This compares to FFO of $1.06 per share a

Federal Realty Investment Trust (FRT) Tops Q2 FFO and Revenue Estimates
Federal Realty Investment Trust (FRT) Tops Q2 FFO and Revenue Estimates

Federal Realty Investment Trust (FRT) came out with quarterly funds from operations (FFO) of $1.91 per share, beating the Zacks Consensus Estimate of $1.73 per share. This compares to FFO of $1.69

Travere Therapeutics (TVTX) Reports Q2 Loss, Tops Revenue Estimates
Travere Therapeutics (TVTX) Reports Q2 Loss, Tops Revenue Estimates

Travere Therapeutics (TVTX) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.9 per share a year ago. These

Bowman Consulting (BWMN) Beats Q2 Earnings and Revenue Estimates
Bowman Consulting (BWMN) Beats Q2 Earnings and Revenue Estimates

Bowman Consulting (BWMN) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to a loss of $0.03 per share a year ago. These

Blue Bird (BLBD) Q3 Earnings and Revenues Top Estimates
Blue Bird (BLBD) Q3 Earnings and Revenues Top Estimates

Blue Bird (BLBD) came out with quarterly earnings of $1.19 per share, beating the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $0.91 per share a year ago. These figures